home / stock / crdl:cc / crdl:cc news


CRDL:CC News and Press, Cardiol Therapeutics Inc. From 07/13/22

Stock Information

Company Name: Cardiol Therapeutics Inc.
Stock Symbol: CRDL:CC
Market: TSXC
Website: cardiolrx.com

Menu

CRDL:CC CRDL:CC Quote CRDL:CC Short CRDL:CC News CRDL:CC Articles CRDL:CC Message Board
Get CRDL:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

CRDL:CC - The Healthcare Companies Fighting the World's Biggest Killers

Palm Beach, FL – July 13, 2022 – FinancialNewsMedia.com News Commentary – Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the healthcare sector are constantly innovating to try to combat these ...

CRDL:CC - Cardiol Therapeutics Reports Results of 2022 Annual General Meeting

Oakville, Ontario--(Newsfile Corp. - June 29, 2022) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( "Cardiol" or the "Company" ), a clinical-stage life sciences company focused on the research and clinical development of cannabidiol as an anti-inflammatory and anti-fibrotic ther...

CRDL:CC - Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDT

Oakville, Ontario--(Newsfile Corp. - June 27, 2022) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( "Cardiol" or the "Company" ), a clinical-stage life sciences company focused on the research and clinical development of cannabidiol as an anti-inflammatory and anti-fibrotic th...

CRDL:CC - Tackling Recurring Health Conditions Offers Hope to Patients

Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly in the case of cancer or heart conditions. This reality is enc...

CRDL:CC - As Health Problems Mount Patients Welcome New Treatments

Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – There are several serious health problems facing society today. Some, like heart disease, gastrointestinal diseases, cancer, and diabetes, pose a growing burden to health care systems and ...

CRDL:CC - Cardiol Therapeutics Announces At-The-Market Equity Offering Program

Oakville, Ontario--(Newsfile Corp. - June 9, 2022) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( "Cardiol" or the "Company" ), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treat...

CRDL:CC - Breakthroughs In Treating Killer Diseases Could Lengthen Life

Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization , top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal conditions, and diabetes. Therefore, discovering viabl...

CRDL:CC - Market Movers. Today's Top Stock Picks For New & Trending Opportunities

Market Movers. Today's Top Stock Picks For New & Trending Opportunities VANCOUVER, BC / ACCESSWIRE / May 27, 2022 / Investors want insight. Welcome to the Market Movers Newsletter where we have created a snapshot of new and trending companies that we think investors will want to know ...

CRDL:CC - Cardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of Directors

Oakville, Ontario--(Newsfile Corp. - May 19, 2022) - Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) ( "Cardiol" or the "Company" ), a clinical-stage life sciences company focused on the research and clinical development of anti-fibrotic and anti-inflammatory therapies for the treat...

CRDL:CC - Why Orphan Drug Designation Offers Several Benefits

Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – The U.S. FDA prioritizes developing new treatments for rare diseases with the ability to grant Orphan Drug Designation . Here we discuss the FDA’s Orphan Drug Designation pro...

Previous 10 Next 10